PRMT1 Promotes the Self‐renewal of Leukemia Stem Cells by Regulating Protein Synthesis
Abstract The application of tyrosine kinase inhibitors (TKIs) has revolutionized the management of chronic myeloid leukemia (CML). However, disease relapse and progression particularly due to persistent leukemia stem cells (LSCs) remain a big challenge in the clinic. Therefore, validation of the the...
Saved in:
Main Authors: | Min Zhou, Yi Huang, Ping Xu, Shuyi Li, Chen Duan, Xiaoying Lin, Shilai Bao, Waiyi Zou, Jingxuan Pan, Chang Liu, Yanli Jin |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2025-02-01
|
Series: | Advanced Science |
Subjects: | |
Online Access: | https://doi.org/10.1002/advs.202308586 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prmt5 is essential for intestinal stem cell maintenance and homeostasis
by: Li Yang, et al.
Published: (2025-02-01) -
The mitochondria as an emerging target of self-renewal in T-cell acute lymphoblastic leukemia
by: Majd A. Al-Hamaly, et al.
Published: (2025-12-01) -
REPEATED THERAPEUTIC LEUKAPHERESIS - A SOLE TREATMENT DURING PREGNANCY AS A BRIDGE BEFORE TYROSINE KINASE INHIBITORS FOR A PREGNANT WOMAN WITH CHRONIC MYELOGENOUS LEUKEMIA – A CASE REPORT AND DISCUSSION
by: Ivan Tonev, et al.
Published: (2025-01-01) -
PRMT6 promotes colorectal cancer progress via activating MYC signaling
by: Xin Zhang, et al.
Published: (2025-01-01) -
TNG908 is a brain-penetrant, MTA-cooperative PRMT5 inhibitor developed for the treatment of MTAP-deleted cancers
by: Kimberly J. Briggs, et al.
Published: (2025-02-01)